Lilly-partnered start-up raises $65 million for RNA-targeting drugs
Haya Therapeutics aims to test its lead drug candidate in humans with the new funds

May 8, 2025 0
May 8, 2025 0
May 8, 2025 0
May 8, 2025 0
May 8, 2025 0
May 4, 2025 0
May 4, 2025 0
May 4, 2025 0
May 8, 2025 0
May 9, 2025 0
May 9, 2025 0
May 9, 2025 0
May 9, 2025 0
May 8, 2025 0
May 8, 2025 0
May 9, 2025 0
May 9, 2025 0
May 9, 2025 0
May 9, 2025 0
Or register with email
Apr 28, 2025 0
Apr 21, 2025 0
May 9, 2025 0
May 9, 2025 0
May 9, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.